Korea's Celltrion Sets Sights on U.S. Market

Celltrion, which sells a cheap version of a top-selling rheumatoid arthritis drug in Europe, is now targeting the U.S., the world’s biggest pharmaceutical market.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news